US Stocks
RNAZ

TransCode Therapeutics, Inc. Common Stock

$9.68
+0.33 (+3.53%)

Volume:

9.876K ($95.60K)

Market Capitalization:

$8.88M

TransCode Therapeutics Price Chart

TransCode Therapeutics Price Chart 8:10 AM 9:30 AM 10:50 AM 12:10 PM 1:30 PM 2:50 PM 4:10 PM9.759.669.579.479.389.299.20

TransCode Therapeutics Volume Chart

TransCode Therapeutics Volume Chart 8:10 AM9:30 AM10:50 AM12:10 PM1:30 PM2:50 PM4:10 PM 3.96K3.40K2.83K2.26K1.70K1.13K566

TransCode Therapeutics Market Segments

After Hours

*No Trades in Segment

Regular Trading Hours

+0.32(+3.42%)
Open$9.36
Close$9.68
Low$9.20
Low Change-0.16 (-1.71%)
High$9.75
High Change+0.39 (+4.17%)
Range$0.55
Volume9.876K
Dollar Volume$95.60K

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$9.50
Close$9.50
Low$9.50
Low Change0.00 (0.00%)
High$9.50
High Change+0.00 (+0.00%)
Range$0.00
Volume100
Dollar Volume$950.00

Regular Trading Hours Yesterday

-0.13(-1.37%)
Open$9.48
Close$9.35
Low$9.32
Low Change-0.17 (-1.74%)
High$9.80
High Change+0.32 (+3.38%)
Range$0.49
Volume9.22K
Dollar Volume$86.21K

Premarket Yesterday

*No Trades in Segment

TransCode Therapeutics Moving Averages

5 Day Moving Average (SMA5)$9.63
10 Day Moving Average (SMA10)$9.72
20 Day Moving Average (SMA20)$9.73
50 Day Moving Average (SMA50)$9.44
100 Day Moving Average (SMA100)$9.46
200 Day Moving Average (SMA200)$9.73

TransCode Therapeutics Statistics

Average Volume (30 Days)415.59K
P/E Ratio (Current)-.33
EPS (Current)-$29.62
Dividend Yield0.00%
Free Cash Flow-$14.52M
Cash Ratio0.96
Current Ratio1.60
Quick Ratio1.60
Debt to Equity0.00
Enterprise Value$6.14M
EV to EBITDA-0.36
EV to Sales
Price to Book6.30
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-5.20%
Return on Equity-19.05%

TransCode Therapeutics Stock Splits

There have been 4 stock splits for TransCode Therapeutics (RNAZ). The last reverse stock split occured on May 15, 2025 and reduced the outstanding shares at a ratio of 28:1.

DateTypeRatio
May 15, 2025Reverse28:1
Dec 4, 2024Reverse33:1
Jan 16, 2024Reverse40:1
May 23, 2023Reverse20:1

TransCode Therapeutics Dividends

There have been no dividends for TransCode Therapeutics (RNAZ).